Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis (Q34270086)

1 August 2017

title

Relationship between brain glutamate levels and clinical outcome in individuals at ultra high risk of psychosis (English)

1 reference

1 August 2017

1 reference

Kate Merritt

7

0 references

Ruth L O'Gorman

Ruth L O'Gorman

13

0 references

Paul Allen

Paul Allen

8

0 references

David Lythgoe

David J Lythgoe

12

0 references

James Stone

James M Stone

2

0 references

Oliver Howes

Oliver D Howes

9

0 references

Gareth J. Barker

Gareth J Barker

4

0 references

Philip McGuire

Philip K McGuire

14

0 references

Robin Murray

Robin M Murray

10

0 references

Christopher A Chaddock

3

Christopher A Chaddock

1 reference

1 August 2017

5

Ilaria Bonoldi

1 reference

1 August 2017

Alice Egerton

1

1 reference

1 August 2017

Rachel M Howard

6

1 reference

1 August 2017

Mary A McLean

11

1 reference

1 August 2017

language of work or name

English

0 references

publication date

11 June 2014

1 reference

1 August 2017

published in

Neuropsychopharmacology

1 reference

1 August 2017

volume

39

1 reference

1 August 2017

issue

12

1 reference

1 August 2017

page(s)

2891-2899

1 reference

Glutamate levels in the associative striatum before and after 4 weeks of antipsychotic treatment in first-episode psychosis: a longitudinal proton magnetic resonance spectroscopy study

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

The psychosis high-risk state: a comprehensive state-of-the-art review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Anterior cingulate glutamate levels related to clinical status following treatment in first-episode schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Glutamate and psychosis risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Glutamate in schizophrenia: a focused review and meta-analysis of ¹H-MRS studies

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Can clinicians predict psychosis in an ultra high risk group?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Field strength dependence of PRESS timings for simultaneous detection of glutamate and glutamine from 1.5 to 7T.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

1H-MRS at 4 tesla in minimally treated early schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

NMDA receptor hypofunction model of schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Cortical development and thalamic pathology in schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Glutamate receptor dysfunction and schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Recent advances in the phencyclidine model of schizophrenia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4180719

Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study

6 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Outreach and support in south London (OASIS), 2001-2011: ten years of early diagnosis and treatment for young individuals at high clinical risk for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Thalamic glutamate levels as a predictor of cortical response during executive functioning in subjects at high risk for psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Childhood traumas: an outline and overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

NMDA antagonist and antipsychotic actions in cortico-subcortical circuits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Aberrant hippocampal activity underlies the dopamine dysregulation in an animal model of schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Proton MRS in twin pairs discordant for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Neuroanatomical abnormalities that predate the onset of psychosis: a multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Comparative reliability of proton spectroscopy techniques designed to improve detection of J-coupled metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Long-term follow-up of a group at ultra high risk ("prodromal") for psychosis: the PACE 400 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

First in vivo evidence of an NMDA receptor deficit in medication-free schizophrenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Thalamic neurochemical abnormalities in individuals with prodromal symptoms of schizophrenia - relationship to auditory event-related potentials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Abnormal thalamic glutamate and liability to psychosis: state or trait marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Glutamate and glutamine measured with 4.0 T proton MRS in never-treated patients with schizophrenia and healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Longitudinal grey-matter and glutamatergic losses in first-episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

3-T proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Hippocampal pathology in individuals at ultra-high risk for psychosis: a multi-modal magnetic resonance study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPP.2014.143

Identification of young people at risk of psychosis: validation of Personal Assessment and Crisis Evaluation Clinic intake criteria

21 January 2018

1 reference

12 December 2020

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

12 December 2020

The psychosis threshold in Ultra High Risk (prodromal) research: Is it valid?

1 reference

12 December 2020

Grey matter and social functioning correlates of glutamatergic metabolite loss in schizophrenia

1 reference

12 December 2020

Identifiers

DOI

10.1038/NPP.2014.143

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference